Please login to the form below

Not currently logged in
Email:
Password:

Panenza given go ahead in France

Sanofi-aventis' non-adjuvanted influenza A (H1N1) 2009 vaccine, Panenza, has received marketing authorisation for use in France

Sanofi-aventis' non-adjuvanted influenza A (H1N1) 2009 vaccine, Panenza, has received marketing authorisation for use in France.

The French drug agency Afssaps (Agence Française de Sécurité Sanitaire des Produits de Santé) has granted marketing authorisation for Panenza, thereby making the vaccine available to French health authorities.

Panenza is produced at the Sanofi Pasteur vaccines division facility in Val de Reuil, France.

Sanofi Pasteur's president and chief executive officer, Wayne Pisano, said: "Registration and on-schedule delivery of A(H1N1) 2009 influenza vaccines remain high priorities for Sanofi Pasteur to help support authorities' pandemic immunisation efforts and address this public health challenge.

"The marketing authorisation approval for Panenza represents a key regulatory step, as this non-adjuvanted vaccine could initially be selected in national immunisation programmes to protect specific populations in some European countries," Pisano added.

Sanofi Pasteur has filed a decentralised marketing authorisation application for Panenza vaccine in six European Union countries: Belgium, France, Germany, Italy, Luxembourg and Spain.

16th November 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Research Partnership

We are one of the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the...

Latest intelligence

Products come and go, but a pharma company’s most valuable, durable asset is its reputation, writes Duncan Mackenzie-Reid and Simon Grist
...
Erik
A quest for innovative solutions
UCB looks to the future through a PRISM...
Big data, privacy and the rise of genomic testing
Blue Latitude Health speaks to Johan Christiaanse, Marketing Director at BGI, to find out how the medical profession can overcome one of the major barriers to precision medicine – big...

Infographics